Fractional laser plus tirbanibulin ointment for basal and squamous cell skin cancers

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This Phase 1/2 interventional trial uses non-ablative fractional lasers (thulium and erbium) and adjunct bulk heating methods on biopsy-confirmed basal cell carcinomas (BCC) and squamous cell carcinomas (SCC). After laser and heating treatment, subjects may apply tirbanibulin 1% ointment over five nights depending on lesion invasiveness. The approach aims to enhance topical drug delivery and achieve tumor clearance without standard surgical excision. Outcomes will include treatment response and safety, with attention to cosmetic results.

Why it matters

Who can join: the full rules

Inclusion Criteria: biopsy confirmed squamous and/or basal cell carcinoma not previously treated by another method.

Exclusion Criteria:

* Cannot be pregnant at the time of treatment

Where it's running

• Bruce Robinson, MD
  New York, New York, United States Recruiting

Study contacts

• Principal investigator: Bruce Robinson, MD — Bruce Robinson, MD
• Study coordinator: Gillian Nanni, Research Coordinator, BS
• Email: info@brucerobinsonmd.com
• Phone: 212-750-7121

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Alpha DaRT treatment for skin squamous cell cancer in immunocompromised patients

  This study tests whether placing Alpha DaRT seeds directly into a skin squamous cell carcinoma can shrink tumors and improve outcomes in people with compromised immune systems.

  Recruiting at 6 sites Alpha Tau Medical LTD. · Gilbert, Arizona and 10 other locations · NCT06615635

• Using Raman Spectroscopy to assess skin cancer tumors

  This study is testing a new imaging technique to see if it can help doctors better understand the size and spread of skin cancer tumors in patients with basal cell and squamous cell carcinoma.

  Recruiting Stony Brook University · Stony Brook, New York · NCT06384924

• Safe use of metformin and naproxen to help prevent cancer in people with Fanconi anemia

  This study tests whether metformin and naproxen can lower the chance of cancer developing in adults with Fanconi anemia.

  Recruiting at 2 sites Phase 1 Rockefeller University · Minneapolis, Minnesota and 1 other locations · NCT07901959

• Mobile sun protection support to help young adults stay safe in the sun

  This project tests a mobile health program to see if reminders, education, planning tools, and real-time sun exposure information can help young adults protect their skin from excessive sun exposure.

  Recruiting University of Utah · Salt Lake City, Utah · NCT07830394

• Two-photon microscopy on skin biopsies to help diagnose skin lesions

  This study tests whether images from two-photon fluorescence microscopy of dermatology biopsies can match the diagnosis determined by standard histology.

  Recruiting University of Rochester · Victor, New York · NCT07773688

• Targeted dual-imaging helper for head and neck cancer surgery

  This study tests whether using two imaging agents during surgery can help doctors see tumors and cancerous lymph nodes in adults with head and neck squamous cell carcinoma.

  Recruiting Phase 1 Vanderbilt-Ingram Cancer Center · Nashville, Tennessee · NCT07741643

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.